Childhood cancers trials in Ireland
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleBiological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
- Where
- Dublin 12
- Age
- 6 months and over
- People
- 433 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05476939 · EU 2023-506027-29-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Dublin
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 3Taking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Cork, Dublin, Dublin 8, Galway
- Age
- 0 years to 45 years
- People
- 6,430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Dublin 4, Dublin 8, Galway
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Dublin 12
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - No phaseTaking peopleChemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events
- Where
- Dublin
- People
- 100
- Run by
- St Vincent's University Hospital, Ireland
See details and how to joinNCT07592234 - Phase 3Taking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Dublin
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - No phaseTaking peopleA Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
- Where
- Dublin
- Age
- 16 years to 30 years
- People
- 80
- Run by
- St. James's Hospital, Ireland
See details and how to joinNCT07561957 - No phaseTaking peopleEffectiveness of Ultrasound-Guided Versus Traditional IV Insertion by Oncology Nurses in Adult Population Recieving Systemic Anti-cancer Therapy
- Where
- Galway
- People
- 98
- Run by
- University of Galway
See details and how to joinNCT07208175 - No phaseEnrolling by invitationTelemedicine Rash Evaluation and Assessment of Toxicity in Skin in Acute Oncology and Haematology Care: A Pilot Study
- Where
- Sligo
- People
- 25
- Run by
- Sligo General Hospital
See details and how to joinNCT07476807 - Phase 1/2Taking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Dublin
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - Phase 1/2Taking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Dublin
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - Phase 1/2Taking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Dublin
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - Phase 3Taking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Dublin 12
- Age
- Up to 21 years
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00 - No phaseTaking peopleE²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
- Where
- Dublin, Galway
- Age
- 12 years and over
- People
- 2,000 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503 - Phase 1/2Taking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Dublin 12
- People
- 1,672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00 - Phase 2Taking peopleTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Dublin
- Age
- Up to 18 years
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00